LAS VEGAS, May 9 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company targeting to become a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide, announced today it has changed its name to China Holdings, Inc.
The name change reflects the Company's new strategy to engage in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance. The name change did not require stockholder approval and the outstanding shares of common and preferred stock will not be affected by the change in name.
The Company's objective is to achieve long-term capital appreciation by investing in companies and other entities with significant assets, revenues, investments, production activities, trading and business interests in China.
About China Health Holdings, Inc.
China Health Holdings, Inc., a wholly owned subsidiary of China Holdings, Inc., is a development stage company targeting to become a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide. The Company's main objective is to partner with SFDA approved drug producers, GMP certified pharmaceutical manufacturing facilities, research and development centers and universities in China. The Company's immediate goals for 2007 include the profitable penetration of the Chinese pharmaceutical industry by acquiring leading pharmaceutical companies in the China. The Company's strategy is to leverage synergies, integrate drug pipelines and distribution channels, and management expertise between pending acquisitions.
Please visit http://www.chinahealthholding.com for more information on the Company.
About China Holdings, Inc.
China Holdings, Inc. is the holding company of two wholly-owned subsidiaries: (i) China Health Holdings, Inc. and (ii) China Health World Trade Corporation. The Company's objective is to achieve long-term capital appreciation by investing in companies and other entities with significant assets, revenues, investments, production activities, trading and business interests in China.
Please visit http://www.chinaholdings.org for more information on the Company.
For Worldwide Investor and Media Inquiries, Please Contact:
China Holdings, Inc., Las Vegas
Mr. Xiaofei Yu
President, Corporate Development
Tel: +1-604-608-6788; +1-877-883-0979 (North America)
Tel: +86-1370-133-1287 (China)
Email: info@chinahealthholding.com
Ogilvy Public Relations Worldwide
Mr. Rory Macpherson
Consultant
Tel: +86-10-8520-6553
Email: rory.macpherson@ogilvy.com
Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.